Form 4 filed by King-Jones Heidy
King-Jones Heidy filed this Form 4 on Spyre Therapeutics, Inc. with 7 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-03 01:30:15 UTC.
- Accession
- 0001636282-26-000119
- Filer
- CIK 1794898
- Filed
- 2026-10-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Spyre Therapeutics, Inc. (CIK 1636282)
- King-Jones Heidy officer (See Remarks)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-01 | M exercised | +28,933 | $14.5 | 31,778 | D |
| Common Stock | 2026-10-01 | S sold | -400 | $89.24 | 31,378 | D |
| Common Stock | 2026-10-01 | S sold | -16,605 | $90.35 | 14,773 | D |
| Common Stock | 2026-10-01 | S sold | -7,228 | $91.35 | 7,545 | D |
| Common Stock | 2026-10-01 | S sold | -2,100 | $92.7 | 5,445 | D |
| Common Stock | 2026-10-01 | S sold | -2,600 | $93.46 | 2,845 | D |
| Stock Option (Right to Buy) derivative | 2026-10-01 | M exercised | -28,933 | $0 | 482,478 | D |